You are here

VIRION SYSTEMS, INC.

Company Information
Address
9610 MEDICAL CENTER DR, STE 100
ROCKVILLE, MD -
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Cotton Rat: Animal Model Predictive of Clinical Responses to HSV Vaccines

    Amount: $557,666.00

    DESCRIPTION (provided by applicant): Genital herpes is one of the most prevalent sexually transmitted infections worldwide and is associated with substantial morbidity. The impact of genital herpes a ...

    STTRPhase I2010Department of Health and Human Services National Institutes of Health
  2. Establishment fo HIV infection in cotton rats

    Amount: $404,560.00

    DESCRIPTION (provided by applicant): The development of a small animal model to study human immunodeficiency virus type-1 (HIV-1) infection would significantly facilitate studies of disease pathogene ...

    SBIRPhase II2007Department of Health and Human Services National Institutes of Health
  3. Novel Model to Predict Safety and Efficacy of Microbicides

    Amount: $495,021.00

    DESCRIPTION (provided by applicant): Genital herpes is one of the most prevalent sexually transmitted infections (STI) worldwide and is associated with substantial morbidity. The impact of genital her ...

    STTRPhase I2006Department of Health and Human Services National Institutes of Health
  4. Treatment of RSV Bronchiolitis with NSAIDs

    Amount: $438,794.00

    DESCRIPTION (provided by applicant): Respiratory Syncytial virus (RSV) is the leading viral cause of death in children under 1 year and is an increasing cause of morbidity and mortality in transplant ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
  5. Novel Model to Predict Safety and Efficacy of Microbicides

    Amount: $495,021.00

    DESCRIPTION (provided by applicant): Genital herpes is one of the most prevalent sexually transmitted infections (STI) worldwide and is associated with substantial morbidity. The impact of genital her ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
  6. Establishment of HIV Infection in cotton rats

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The development of a small animal model to study human immunodeficiency virus type-1 (HIV-1) infection would significantly facilitate studies on disease pathogene ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  7. Mucosal RSV vaccine using CpG oligodeoxynucleotides

    Amount: $100,001.00

    DESCRIPTION (provided by applicant): Oligodeoxynucleotides containing certain unmethylated CpG sequences (CpG ODN) are powerful immunostimulants when co-administered with a variety of antigens, making ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  8. NOVEL NEISSERIA MENINGIDITIS A AND C CONJUGATE VACCINE

    Amount: $100,000.00

    N/A

    SBIRPhase I1998Department of Health and Human Services
  9. Immunotherapy of Viral Pneumonias of Infants

    Amount: $744,976.00

    Malaria is a major parasitic disease in humans. Induction of immunity to the sexual stages, found in the mosquito host, is an important element in controlling the parasite. We have devised a conjugate ...

    SBIRPhase II1996Department of Health and Human Services
  10. Peptide-Based HIV Conjugate Vaccine

    Amount: $55,555.00

    HIV is a significant problem worldwide. Considerable effort is being made to develop a vaccinewhich elicits high titers of neutralizing antibodies, which have been correlated with long term protection ...

    SBIRPhase I1994Department of Health and Human Services
US Flag An Official Website of the United States Government